conference coverage
conference coverage
03/31/2024

Kari E. Hacker, MD, PhD

Kari E. Hacker, MD, PhD
In this video, Kari E. Hacker, MD, PhD, discusses the results of her team's study examining the rate of HER2-expression among patients with endometrial cancer, as well as the eligibility of these patient...
03/31/2024
conference coverage
conference coverage
03/31/2024

Kari E. Hacker, MD, PhD

Kari E. Hacker, MD, PhD
In this video, Kari E. Hacker, MD, PhD, discusses the results of her team's study examining the rate of HER2-expression among patients with endometrial cancer, as well as the eligibility of these patient...
03/31/2024
Video
Video
03/31/2024
Jeffrey A. Sparks, MD, MMSc
In this video, Jeffrey A. Sparks, MD, MMSc, discusses his study that evaluated the outcomes of patients with pre-existing rheumatoid arthritis (RA) who initiated immune checkpoint inhibitors for cancer, if...
03/31/2024
Video
Video
03/31/2024
Jeffrey A. Sparks, MD, MMSc
In this video, Jeffrey A. Sparks, MD, MMSc, discusses his study that evaluated the outcomes of patients with pre-existing rheumatoid arthritis (RA) who initiated immune checkpoint inhibitors for cancer, if...
03/31/2024
Video
Video
03/31/2024
Jeffrey A. Sparks, MD, MMSc
In this video, Jeffrey A. Sparks, MD, MMSc, discusses his study that evaluated the outcomes of patients with pre-existing rheumatoid arthritis (RA) who initiated immune checkpoint inhibitors for cancer, if...
03/31/2024
Video
Video
03/31/2024
Jeffrey A. Sparks, MD, MMSc
In this video, Jeffrey A. Sparks, MD, MMSc, discusses his study that evaluated the outcomes of patients with pre-existing rheumatoid arthritis (RA) who initiated immune checkpoint inhibitors for cancer, if...
03/31/2024
Video
Video
03/31/2024
Jeffrey A. Sparks, MD, MMSc
In this video, Jeffrey A. Sparks, MD, MMSc, discusses his study that evaluated the outcomes of patients with pre-existing rheumatoid arthritis (RA) who initiated immune checkpoint inhibitors for cancer, if...
03/31/2024
Video
Video
03/31/2024
Jeffrey A. Sparks, MD, MMSc
In this video, Jeffrey A. Sparks, MD, MMSc, discusses his study that evaluated the outcomes of patients with pre-existing rheumatoid arthritis (RA) who initiated immune checkpoint inhibitors for cancer, if...
03/31/2024
Video
Video
03/25/2024
Brenden P. Lucy, MD
In a small clinical trial, researchers found that patients taking suvorexant, an FDA-approved treatment for insomnia, had reduced levels of amyloid beta (amyloid-β) and tau phosphorylation proteins, which...
03/25/2024
Video
Video
03/25/2024
Brenden P. Lucy, MD
In a small clinical trial, researchers found that patients taking suvorexant, an FDA-approved treatment for insomnia, had reduced levels of amyloid beta (amyloid-β) and tau phosphorylation proteins, which...
03/25/2024